Shamburg News · 8-K filed Nov 12, 2026, 9:00 AM EST
NexGel Announces Noteholder Conversion Agreements and $1.276 Million Financing Tied to Proposed Merger
NXGL · NEXGEL, INC.
- Material agreement
- Financing
- Acquisition
- Other event
- Materiality: high
On November 10, 2026, NexGel entered into Note Amendment and Conversion Agreements with holders of about $14.125 million of its $14.885 million convertible notes, conditioned on completion of a proposed related-party merger with Fountainhead LifeSciences and its affiliates. The Company also entered a Securities Purchase Agreement for a private placement at $5.50 per share with five-year warrants at $10.00 per share, with commitments of about $1.276 million for the initial closing, including $732 thousand from Sequence LifeScience. No definitive merger agreement has been signed, and the conversions are not effective until the merger closes.
Source: SEC EDGAR, Form 8-K, Items 1.01, 2.03, 3.02, 8.01, 9.01, accession 0001493152-26-051238.
Written from the filing by Shamburg Markets. Figures are as reported by the company.